-
2023-505579-53-00
5
2022-10-25
Diffuse large B-cell lymphoma (DLBCL)
-
2023-506927-27-00
5
2022-08-29
Children with short stature either born small for gestational age or w
-
2024-514630-21-00
4
2022-08-11
HER2 positive (HER2+), Hormone Receptor positive (HR+) Early-stage Bre
-
2023-505974-14-00
5
2022-06-23
Multiple Sclerosis (MS)
-
2023-509345-12-00
5
2022-06-22
Multiple Sclerosis
-
2023-504737-41-00
5
2022-06-10
Moderately to Severely Active Crohn's Disease
-
2023-507795-51-00
5
2022-05-17
atherosclerotic heart and blood vessel disease (the narrowing of arter
-
2023-506761-65-00
10
2022-04-08
Spinal Muscular Atrophy (SMA)
-
2023-506516-40-00
5
2022-02-11
Relapsing-Remitting Multiple Sclerosis
-
2023-509372-41-00
5
2022-01-30
Multiple Sclerosis
-
2022-502619-13-00
4
2022-01-25
Relapsing Multiple Sclerosis
-
2024-510735-21-00
5
2021-11-26
Atherosclerotic cardiovascular disease (ASCVD)
-
2023-506926-35-00
5
2021-09-24
Atherosclerotic cardiovascular disease, chronic kidney disease and sys
-
2023-507494-18-00
5
2021-09-24
Non-small cell lung cancer with ROS proto-oncogene 1, receptor tyrosin
-
2023-504734-21-00
5
2021-08-30
Psoriatic arthritis (PsA)
-
2023-507697-40-00
5
2021-07-05
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
-
2022-502122-41-00
5
2021-05-11
Clear cell renal cancer
-
2023-505615-21-00
5
2021-04-28
Muscle Invasive Bladder Cancer
-
2023-507274-40-00
3
2021-04-22
Myelofibrosis
-
2023-506962-30-00
5
2021-03-29
Non-alcoholic steatohepatitis (NASH)
-
2023-506832-33-00
5
2019-11-06
haemophilia A (HA) with inhibitors and haemophilia B (HB) with inhibit
-
2023-505980-36-00
5
2019-09-19
Primary progressive multiple sclerosis (PPMS)
-
2023-505624-56-00
5
2019-08-07
Relapsing Remitting Multiple Sclerosis (RRMS)
-
2023-505478-14-00
5
2019-05-09
Psoriatic Arthritis